Hiroki Hosoi

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia

Jianbiao Zhou, Jessie Yiying Quah, Yvonne Ng et al. · Haematologica · 2019 · 78 citations · Full text

Hematological Malignancy, Dihydroorotate Dehydrogenase, Chemoprevention Strategy +12

Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?

S Tabata, Hiroki Hosoi, Shogo Murata et al. · Journal of Autoimmunity · 2021 · 39 citations · Full text

Vaccination, Long Covid, Viral Persistence +8

Acute Leukemia Showing t(8;22)(p11;q11), Myelodysplasia, CD13/CD33/CD19 Expression and Immunoglobulin Heavy Chain Gene Rearrangement

Masaya Shimanuki, Takashi Sonoki, Hiroki Hosoi et al. · Acta Haematologica · 2013 · 16 citations

Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib

Yusuke Yamashita, Shuhei Morita, Hiroki Hosoi et al. · International Journal of Molecular Sciences · 2020 · 15 citations · Full text

Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines

Hiroki Hosoi, Akiko Niibori-Nambu, Giselle Sek Suan Nah et al. · Gene · 2021 · 12 citations · Full text

Molecular Virology, Immunology, Viral Pathogenesis +4